Tweet This

Average Length of Stay (ALOS)

This refers to how long, on average, patients are inpatients in a hospital. This can sometimes be used as a measure of efficiency, but it is not necessarily correlated with quality of care.

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is…